CDGs variant‐related familial cancer may be very rare and span many different genes beyond previous studies, and whole‐genome sequencing (WGS) has not been applied to analyze variants of all CDGs, which may explain why germline P variants in many familial cancers have not been identified. This evidence concerns the gene PMM2 and hereditary cancer.